Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-10 6:51 pm Purchase |
2025-01-06 | 13G | BioLineRx Ltd. BLRX |
Mitchell P. Kopin | 2,555,903 4.990% |
2,077,581 (+434.35%) |
Filing History |
| 2023-10-26 2:18 pm Purchase |
2023-10-09 | 13D | BioLineRx Ltd. BLRX |
Hong Seng Technology Ltd | 2,560,926 9.500% |
2,560,926 (New Position) |
Filing History |
| 2022-02-11 06:49 am Purchase |
2021-12-31 | 13G | Akanda Corp. AKAN |
Mitchell P. Kopin | 9,285 1.000% |
9,285 (New Position) |
Filing History |
| 2021-02-16 4:10 pm Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
NOVARTIS INC | 125,000 1.000% |
116,667 (+1400.00%) |
Filing History |
| 2021-02-12 9:40 pm Sale |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
Altium Capital Management LLC | 450,262 3.700% |
-187,500 (-29.40%) |
Filing History |
| 2021-02-12 4:05 pm Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
SENVEST MANAGEMENT, LLC | 68,125 0.770% |
68,125 (New Position) |
Filing History |
| 2021-01-29 06:19 am Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
Mitchell P. Kopin | 478,322 5.200% |
478,322 (New Position) |
Filing History |
| 2021-01-06 12:19 pm Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
SABBY MANAGEMENT LLC | 29,039 11.000% |
468 (+1.64%) |
Filing History |
| 2020-11-03 4:39 pm Sale |
2020-10-30 | 13G | BioLineRx Ltd. BLRX |
BIOTECHNOLOGY VALUE FUND L P | 148,671 1.900% |
-632,391 (-80.97%) |
Filing History |
| 2020-06-05 4:16 pm Purchase |
2020-05-26 | 13G | BioLineRx Ltd. BLRX |
Armistice Capital, LLC | 25,952 4.990% |
25,952 (New Position) |
Filing History |
| 2020-06-04 9:13 pm Purchase |
2020-05-26 | 13G | BioLineRx Ltd. BLRX |
Altium Capital Management LLC | 637,762 8.600% |
637,762 (New Position) |
Filing History |
| 2020-06-04 7:06 pm Purchase |
2020-05-26 | 13G | BioLineRx Ltd. BLRX |
Mitchell P. Kopin | 478,322 6.100% |
478,322 (New Position) |
Filing History |
| 2020-06-01 5:37 pm Sale |
2020-05-28 | 13G | BioLineRx Ltd. BLRX |
BIOTECHNOLOGY VALUE FUND L P | 781,062 11.800% |
-17,498 (-2.19%) |
Filing History |
| 2020-05-26 2:54 pm Purchase |
2020-05-26 | 13G | BioLineRx Ltd. BLRX |
SABBY MANAGEMENT LLC | 28,571 11.000% |
28,571 (New Position) |
Filing History |